Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Blocklisting Six Monthly Return

5 Dec 2008 14:28

RNS Number : 6401J
Ark Therapeutics Group PLC
05 December 2008
 



Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Unapproved Share Option Scheme 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

2,536,252

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

5,000

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

2,531,252

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Enterprise Management Incentive Share Option Plan 

3.  Period of return

From 3/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

939,433

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

Nil

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

939,433

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group 2005 Long Term Incentive Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

7,750

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

992,250

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

  Ark Therapeutics Group plc

5 December 2008

BLOCKLISTING SIX MONTHLY RETURN

1.  Name of applicant

Ark Therapeutics Group plc

2.  Name of scheme

Ark Therapeutics Group Approved Share Option Plan

3.  Period of return

From 9/6/2008 - 2/12/2008

4. Balance of unallotted securities under scheme from previous return

Nil

 

5. Plus: The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return (if any increase has been applied for)

1,000,000

6.  Less: Number of securities issued/allotted under the scheme during period

Nil

7.  Equals: Balance under the scheme not yet issued/allotted at end of period

1,000,000

Name of contact:

Martyn Williams, Company Secretary

Telephone number of contact:

0207 388 7722

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BLRUVUSRWRRURAA
Date   Source Headline
21st Mar 20054:29 pmRNSDirector Shareholding
21st Mar 20054:21 pmRNSDirector Shareholding
14th Mar 20055:55 pmRNSDirector's Share Dealing
14th Mar 20055:06 pmRNSDirector Shareholding
14th Mar 20055:00 pmRNSDirector Shareholding
10th Mar 20057:01 amRNSFinal Results
21st Jan 20057:00 amRNSGranted Patent
19th Jan 20054:21 pmRNSInterest in Shares
17th Jan 20057:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.